RxDoctor Payments Data

Joseph Kaempf

Medical · East Patchogue, NYNPI 1770079444

Payments from drug & device makers

$3,420in general payments, 2019–2025

Across 118 payments — averaging $28.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$903
  • Amgen$894
  • Lilly USA, LLC$249
  • Novo Nordisk$240
  • Idorsia Pharmaceuticals US Inc$192
  • Kowa Pharmaceuticals America, Inc.$164
  • plus $778 from 16 others

What the payments were for

  • Food & beverage$3,420100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,420 in reported general payments places this provider in the 85th percentile of 2,395 medical providers in New York.

See all medical providers in New York

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide45$65,285
JardianceEmpagliflozin24$33,075
Repatha SureclickEvolocumab25$25,608
EliquisApixaban21$24,781
Trelegy ElliptaFluticasone/Umeclidin/Vilanter17$18,489
XareltoRivaroxaban16$17,634
FarxigaDapagliflozin Propanediol14$16,329
MounjaroTirzepatide13$13,178
Toujeo SolostarInsulin Glargine,hum.Rec.Anlog12$5,606
VascepaIcosapent Ethyl11$3,736
EdarbyclorAzilsartan Med/Chlorthalidone12$2,826
Rosuvastatin Calcium186$1,907
Albuterol Sulfate HfaAlbuterol Sulfate56$1,755
Metoprolol Succinate82$1,407
Telmisartan-HydrochlorothiazidTelmisartan/Hydrochlorothiazid14$1,048

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$240$65,28545 claims
Boehringer IngelheimJardiance$52$33,07524 claims
PfizerEliquis$62$24,78121 claims
GSKTrelegy Ellipta$108$18,48917 claims
Johnson & JohnsonXarelto$20$17,63416 claims
AstraZenecaFarxiga$903$16,32914 claims
Lilly USA, LLCMounjaro$249$13,17813 claims
AbbVieSynthroid$127$53013 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 2,395 medical providers in New York.

Other medical in East Patchogue

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →